Related Experiment Video
Updated: Jun 12, 2026

09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
microRNAs, RNA binding proteins and cancer
1Division of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.agami@nki.nl
European Journal of Clinical Investigation
|May 22, 2010
Summary
RNA-binding proteins (RBPs) regulate microRNAs (miRNAs), which are key gene regulators. Understanding the interplay between RBPs and miRNAs is crucial for comprehending their roles in both normal development and cancer progression.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression, influencing cellular processes.
- miRNAs function by inhibiting gene expression via interaction with messenger RNA (mRNA) 3'-untranslated regions.
- RNA-binding proteins (RBPs) are increasingly recognized for their roles in miRNA biogenesis, activity, and stability.
Purpose of the Study:
- To investigate the intricate relationship between RNA-binding proteins (RBPs) and microRNAs (miRNAs).
- To elucidate how the interplay between RBPs and miRNAs impacts gene expression.
- To explore the functional consequences of RBP-miRNA interactions in biological processes, including cancer.
Main Methods:
- Literature review and synthesis of existing research on miRNA and RBP interactions.
- Analysis of molecular mechanisms governing miRNA biogenesis and function.
- Examination of RBP involvement in miRNA regulation across different cellular contexts.
Main Results:
- RBPs significantly influence miRNA biogenesis, activity, and stability.
- The interplay between RBPs and miRNAs affects gene expression critical for development, stem cell maintenance, and stress responses.
- The specific impact of RBPs on miRNA function in cancer remains largely understudied.
Conclusions:
- RBPs and miRNAs engage in complex regulatory crosstalk affecting gene expression.
- Further research is needed to fully understand how RBPs modulate miRNA functions, particularly in the context of cancer.
- Elucidating RBP-miRNA interactions may reveal novel therapeutic targets for cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...

